GW Pharma (GWPH) Lower as Bid Speculation Questioned

September 9, 2016 8:18 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

After surging 24% over the past few sessions following reports from Reuters the company has been approached for a sale, GW Pharma (NASDAQ: GWPH) is down 5.5% in pre-open trade Friday as the speculation is questioned. Traders are pointing to a DailyMail report that tamps down expectations on an imminent deal.

The report highlights that the company has ample cash and can afford to go it alone. Also, a company spokesperson points out that Morgan Stanley, the bank said to be fielding GWPH offers, has acted as its banker for a many years (so nothing new there).

It should also be noted that the company is still presenting at next week's Morgan Stanley Healthcare Conference (09/14) and Morgan Stanley analysts have not restricted coverage of the stock.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Related Entities

Morgan Stanley, Pre Market Movers

Add Your Comment